FDA warns Chinese drug maker over lying
(By Ed Silverman for STAT) The next time that employees at Xiamen Origin Biotech want to lie to regulators about
Read More
Part D/Prescription Drugs
In cancer, it’s back to the future as old treatments make cutting-edge ones more effective
(By Sharon Begley for STAT) New cancer drugs that unleash the immune system on tumors are all the rage, getting
Read MoreUS researchers now testing Zika vaccines in human subjects
(By Andrew Joseph for STAT) Federal health researchers have started testing an experimental Zika vaccine in people, officials announced Wednesday.
Read MoreThere’s a possible cure for ‘bubble boy’ disease. It will cost $665,000
(By Damian Garde for STAT) GlaxoSmithKline has developed what looks like a cure for a rare and deadly disease, and
Read MoreMost Californians support a measure to obtain state discounts on drugs
(By Ed Silverman for STAT) The pharmaceutical industry may be losing a heated battle over drug prices in California. Continue
Read MoreGilead fires back at medical journal report critical of its pricing
(By Ed Silverman for STAT) After getting beaten up last week over the pricing of its hepatitis C treatments in
Read MorePharmacy benefit managers are restricting access to lots of drugs next year
(By Ed Silverman for STAT) In the latest bid to control prescription drug spending, the nation’s largest pharmacy benefits managers
Read MoreThe ‘gouge factor’: Big companies want transparency in drug price negotiations
(By Ed Silverman for STAT) The path that prescription drugs take from the lab to your medicine chest is a
Read MoreStudy Bodes Well For Biosimilars But Highlights Need For More Research
(By Sydney Lupkin for Kaiser Health News) Research released Monday finds comparable safety and efficacy for one type of biosimilar
Read MoreWhat instructions? Majority of Americans misuse prescription drugs
(By Ed Silverman for STAT) Many Americans appear to be misusing their prescription drugs in ways that put their health
Read More